Search

everythinglearnresearchcommunity

for

Search:↓

AcSDKP may help prevent skin and hair aging and promote their growth.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Both treatments for alopecia areata are equally effective and safe.

Researchers created a skin graft that senses blood glucose and could treat diabetes using CRISPR-edited stem cells.

Resveratrol activates the Nrf2 pathway in human skin, significantly increasing the production and distribution of the antioxidant glutathione.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

AtCSLD3 and GhCSLD3 genes enhance root growth and cell elongation in plants.

More research is needed to understand if GLP-1 agonists affect hair health.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Upadacitinib improved multiple immune-related conditions in one patient.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

EGFR inhibitors for lung cancer can cause severe skin issues.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.